Expression of α‐SMA at tumour front but not tumour centre had prognostic value for patient survival, indicating that tumour front is essential for evaluating stromal molecules as prognostic biomarkers in HNSCC. This evidence concerns the gene ACTA1 and head and neck squamous cell carcinoma.